This study investigated the effects of low-dose tranexamic acid on post-coronary artery bypass surgery bleeding.
Background
Diffuse microvascular bleeding is still a common problem after cardiac procedures. This study was designed to evaluate the hemostatic effects of low-dose tranexamic acid in on-pump coronary artery bypass graft surgery.
Methods
In this prospective randomized placebo-controlled study, 150 patients who were candidates for coronary artery bypass were enrolled and randomly assigned to 1 of 2 groups (tranexamic acid or placebo). Total drainage volume and the need for transfusion as well as surgical complications were recorded and compared in the 2 groups.
Results
There was significantly less mediastinal chest tube drainage up to 48 h in the tranexamic acid group (432 ± 210 mL) compared to the placebo group (649 ± 235 mL, p = 0.006). In the placebo group, 43 (58%) patients were given allogeneic blood during hospital stay compared to 22 (25%) in the tranexamic acid group (p < 0.001). No significant difference in postoperative complications was seen.
Conclusion
The use of low-dose tranexamic acid can significantly reduce blood loss and need for transfusion, with no increase in complications.
TrudellJMcMurdyN. Current antifibrinolytic therapy for coronary artery revascularization. AANA J2008; 76: 121–124.
2.
DailyPOLamphereJADembitskyWPAdamsonRMDansNF. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study. J Thorac Cardiovasc Surg1994; 108: 99–106.
3.
KevySVGlickmanRMBernhardWFDiamondLKGrossRE. The pathogenesis and control of the hemorrhagic defect in open heart surgery. Surg Gynecol Obstet1966; 123: 313–318.
4.
MakwanaJParanjapeSGoswamiJ. Antifibrinolytics in liver surgery. Indian J Anaesth2010; 54: 489–495.
5.
DunnCJGoaKL. Tranexamic acid: a review of its use in surgery and other indications. Drugs1999; 57: 1005–1032.
6.
FodstadHForssellALiliequistBSchannongM. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial. Neurosurgery1981; 8: 158–165.
7.
CasatiVBellottiFGerliC. Tranexamic acid administration after cardiac surgery: a prospective, randomized, double-blind, placebo-controlled study. Anesthesiology2001; 94: 8–14.
8.
RoystonD. Tranexamic acid in cardiac surgery: is there a cause for concern [Review]?Crit Care2010; 14: 194–194.
9.
KarskiJMTeasdaleSJNormanP. Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial. J Thorac Cardiovasc Surg1995; 110: 835–842.
10.
MonganPDBrownRSThwaitesBK. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization. Anesth Analg1998; 87: 258–265.
11.
DrydenPJO'ConnorJPJamiesonWR. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery. Can J Anaesth1997; 44: 934–941.
12.
LambertWBriseboisFJWhartonTJCarrierRCBoyleDRoweBH. The effectiveness of low dose tranexamic acid in primary cardiac surgery. Can J Anaesth1998; 45: 571–574.
13.
HorrowJCVan RiperDFStrongMDBrodskyIParmetJL. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991; 84: 2063–2070.
14.
BlauhutBHarringerWBettelheimPDoranJESpäthPLundsgaard-HansenP. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg1994; 108: 1083–1091.
15.
CoffeyAPittmamJHalbrookHFehrenbacherJBeckmanDHormuthD. The use of tranexamic acid to reduce postoperative bleeding following cardiac surgery: a double-blind randomized trial. Am Surg1995; 61: 566–568.
16.
SpeekenbrinkRGVonkABWildevuurCREijsmanL. Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting. Ann Thorac Surg1995; 59: 438–442.
AnderssonLNilsoonIMColleenSGranstrandBMelanderB. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA. Ann NY Acad Sci1968; 146: 642–658.
19.
SoslauGHorrowJBrodskyI. Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol1991; 38: 113–119.
20.
HorrowJCVan RiperDFStrongMDGrunewaldKEParmetJL. The dose-response relationship of tranexamic acid. Anesthesiology1995; 82: 383–392.
21.
PleymHStensethRWahbaABjellaLKarevoldADaleO. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesth Analg2003; 96: 923–928.
22.
ArmellinGVinciguerraABonatoRPittarelloDGironGP. Tranexamic acid in primary CABG surgery: high vs low dose. Minerva Anestesiol2004; 70: 97–107.
23.
VerstraeteM. Clinical application of inhibitors of fibrinolysis. Drugs1985; 29: 236–261.
24.
ChandlerWLFitchJCWallMH. Individual variations in the fibrinolytic response during and after cardiopulmonary bypass. Thromb Haemost1995; 74: 1293–1297.
25.
FawzyHElmistekawyEBonneauDLatterDErrettL. Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial. J Cardiothorac Surg2009; 4: 25–25.
26.
MartinKWiesnerGBreuerTLangeRTassaniP. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg2008; 107: 1783–1790.
27.
MurkinJMFalterFGrantonJYoungBBurtCChuM. High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg2010; 110: 350–353.
28.
LaupacisAFergussonD. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Anesth Analg1997; 85: 1258–1267.
29.
LeviMCromheeckeMEde JongeE. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet1999; 354: 1940–1947.
30.
RuelMAWangFBourkeME. Is tranexamic acid safe in patients undergoing coronary endarterectomy?Ann Thorac Surg2001; 71: 1508–1511.
31.
OvrumEAm HolenEAbdelnoorMOysteseRRingdalML. Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations. J Thorac Cardiovasc Surg1993; 105: 78–83.
32.
KaufmanDWShapiroS. Epidemiological assessment of drug-induced disease [Review]. Lancet2000; 356: 1339–1343.
